世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

次世代シーケンス(NGS)インフォマティクス市場 - 世界の産業規模、シェア、動向、競争、機会、および予測、2018-2028製品・サービス別(ストレージおよびコンピューティングツール、商用データ分析、データ解釈、およびレポーティングツール、次世代シーケンス(NGS)ラボ情報管理システム(LIMS)、用途別(創薬、遺伝子スクリーニング、疾病診断、その他)、エンドユーザー別(病院・診断センター、製薬・バイオテクノロジー企業、学術・研究機関)、地域別


Next Generation Sequencing (NGS) Informatics Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028Segmented By Products & Services (Storage and Computing Tools, Commercial Data Analysis, Data Interpretation, and Reporting Tools, Next Generation Sequencing (NGS) Laboratory Information Management Systems (LIMS), By Application (Drug Discovery, Genetic Screening, Disease Diagnosis, and Others), By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutions), By Region

次世代シーケンシング(NGS)インフォマティクスの世界市場は、癌の有病率の増加と次世代シーケンシング(NGS)の臨床応用の増加により、予測期間2024-2028年に目覚ましい成長を遂げると予測される。Global Cance... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechSci Research
テックサイリサーチ
2023年8月1日 US$4,900
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
114 英語

 

サマリー

次世代シーケンシング(NGS)インフォマティクスの世界市場は、癌の有病率の増加と次世代シーケンシング(NGS)の臨床応用の増加により、予測期間2024-2028年に目覚ましい成長を遂げると予測される。Global Cancer Observatoryによると、2020年には世界中で約19,292,789件の新たながん症例が報告された。乳がん、肺がん、大腸がん、前立腺がん、胃がんなどが2020年に報告されたがん症例の中で最も多いタイプであった。さらに、DNAシーケンスのサンプル数の増加、次世代シーケンシング(NGS)インフォマティクスの使用によるDNAシーケンスのコスト削減、さまざまな政府のイニシアチブ、臨床応用の増加、次世代シーケンシング(NGS)によるマイクロアレイ技術の代替は、市場成長に寄与する他の要因である。
新しいウイルス性疾患の流行の増加は、次世代シーケンス(NGS)インフォマティクス市場の需要を大幅に増加させています。さらに、世界中のさまざまな政府や製薬・バイオテクノロジー企業によって開始されている研究開発活動の増加は、今後数年間における次世代シーケンス(NGS)インフォマティクス市場の成長に有利な機会を生み出すと期待されています。2021年、世界中の製薬業界における研究開発費は約2,380億米ドルでした。
慢性疾患の有病率の上昇
世界的に、がんは死因のトップである。世界保健機関(WHO)によると、過去5年間に世界中で約50,550,287件のがんが報告されている。これは、紫外線や電離放射線のような物理的発がん物質、アスベスト、タバコの煙、アルコール、アフラトキシン(食品汚染物質)、ヒ素(飲料水汚染物質)のような化学的発がん物質、寄生虫感染や不健康なライフスタイルの選択のような生物学的発がん物質の存在によるものである。現在、医療における大きな問題はがんである。新規のがん治療に対する需要は、世界の次世代シーケンス(NGS)インフォマティクス市場の拡大に拍車をかけると予想されます。
.同様に、HIV、ヒトパピローマウイルス、結核など、致命的で潜在的な治療法を必要とする新たなウイルス性疾患の流行の増加は、次世代シーケンス(NGS)インフォマティクスの世界市場の成長をさらに促進すると予想されます。2021年現在、世界全体で約3,840万人がHIVに感染しています。

次世代シーケンサー(NGS)の臨床研究の増加
臨床研究は、観察研究と臨床試験の2つの要素からなる医学研究です。臨床研究活動は、次世代シーケンシング(NGS)を通じてウイルスゲノム配列を特定することにより、ヒトの健康管理につながります。次世代シーケンシング(NGS)技術は、ウイルスゲノムの変異とそれがヒトの健康にも及ぼす影響を研究する上で重要な役割を果たしている。Clinical OMICSに掲載された研究論文によると、2020年、コロナウイルスの約84,000のウイルスゲノム配列がGlobal Initiative to Share All Influenza Data(GISAID)にアップロードされた。さらに、全ゲノムおよびトランスクリプトームシーケンス、メタゲノミクスなどのアプリケーションは、さまざまな微生物サンプルの特性評価に使用されており、これが世界の次世代シーケンス(NGS)インフォマティクス市場の成長を促進すると期待されています。

DNAマイクロアレイ技術の代替
最近の進歩とシーケンスコストの急激な低下により、次世代シーケンス(Next Generation Sequencing (NGS))の人気が急上昇しています。コストが高額でなくなり、方法がよりシンプルで広く普及するにつれて、研究者はゲノムアプリケーションの多くでマイクロアレイよりも次世代シーケンス(NGS)を選択するようになっています。さらに、次世代シーケンシング(NGS)は、さらに高い解像度とゲノムの包括的なビューを提供する可能性を秘めている。
このことは、次世代シーケンシング(NGS)シーケンサーをヒトの健康治療に活用するために、世界中で多くの研究開発が行われていることを明確に示しており、それによって世界の次世代シーケンシング(NGS)インフォマティクス市場の成長を支えています。

市場区分
次世代シーケンサー(NGS)インフォマティクスの世界市場は、製品・サービス、用途、エンドユーザー、地域、競争環境に基づいてセグメント化できます。製品&サービスに基づいて、市場はストレージおよびコンピューティングツール、商用データ分析、データ解釈、およびレポーティングツール、次世代シーケンス(NGS)、ラボ情報管理システム(LIMS)に分類することができます。アプリケーションに基づくと、市場は創薬、遺伝子スクリーニング、疾病診断、その他に細分化される。エンドユーザーに基づくと、市場は病院・診断センター、製薬・バイオテクノロジー企業、学術・研究機関に分けられる。

企業プロフィール
Abbott Laboratories, Inc.、F. Hoffmann-La Roche Ltd.、PerkinElmer, Inc.、SOPHiA GENETICS SA、Precigen, Inc.、QIAGEN N.V.、Illumina, Inc.、Agilent Technologies, Inc.、Eagle Genomics Limited、BGI Genomics Co, Ltd.は、世界の次世代シーケンス(NGS)インフォマティクス市場で事業を展開する主要企業の一部です。

レポートの範囲
本レポートでは、次世代シーケンサー(NGS)インフォマティクスの世界市場を、以下に詳述する業界動向に加えて、以下のカテゴリーに分類しています:
- 次世代シーケンス(NGS)インフォマティクス市場:製品・サービス別
o ストレージとコンピューティングツール
o 商用データ解析
o データ解釈およびレポーティングツール
o 次世代シーケンス(NGS)
o 臨床検査情報管理システム(LIMS)
- 次世代シーケンス(NGS)インフォマティクス市場、用途別
o 創薬
o 遺伝子スクリーニング
o 疾患診断
o その他
- 次世代シーケンス(NGS)インフォマティクス市場:エンドユーザー別
o 病院および診断センター
o 製薬・バイオテクノロジー企業
o 学術・研究機関
- 次世代シーケンス(NGS)インフォマティクス市場:地域別
o 北米
 米国
 カナダ
 メキシコ
欧州
 ドイツ
 フランス
 イギリス
 イタリア
 スペイン
o アジア太平洋
 中国
 日本
 インド
 韓国
 オーストラリア
南米
 ブラジル
 アルゼンチン
 コロンビア
中東・アフリカ
 アラブ首長国連邦
 サウジアラビア
 南アフリカ
 トルコ
 エジプト
競争状況
企業プロフィール:世界の次世代シーケンス(NGS)インフォマティクス市場に存在する主要企業の詳細分析。
利用可能なカスタマイズ:
TechSci Research社は、与えられた市場データをもとに、企業固有のニーズに応じてカスタマイズを提供します。本レポートでは以下のカスタマイズが可能です:
企業情報
- 追加市場参入企業(最大5社)の詳細分析とプロファイリング

ページTOPに戻る


目次

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Next Generation Sequencing (NGS) Informatics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Products & Services (Storage and Computing Tools, Commercial Data Analysis, Data Interpretation, and Reporting Tools, Next Generation Sequencing (NGS) Informatics Services, Laboratory Information Management Systems (LIMS))
5.2.2. By Application (Drug Discovery, Genetic Screening, Disease Diagnosis, and Others)
5.2.3. By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutions)
5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)
5.2.5. By Company (2022)
5.3. Market Map
5.3.1. By Products & Services
5.3.2. By Application
5.3.3. By End User
5.3.4. By Region
6. North America Next Generation Sequencing (NGS) Informatics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Products & Services
6.2.2. By Application
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Next Generation Sequencing (NGS) Informatics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Products & Services
6.3.1.2.2. By Application
6.3.1.2.3. By End User
6.3.2. Canada Next Generation Sequencing (NGS) Informatics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Products & Services
6.3.2.2.2. By Application
6.3.2.2.3. By End User
6.3.3. Mexico Next Generation Sequencing (NGS) Informatics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Products & Services
6.3.3.2.2. By Application
6.3.3.2.3. By End User
7. Europe Next Generation Sequencing (NGS) Informatics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Products & Services
7.2.2. By Application
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Products & Services
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.1.2.4. By Country
7.3.2. France Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Products & Services
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. United Kingdom Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Products & Services
7.3.3.2.2. By Application
7.3.3.2.3. By End User
7.3.4. Italy Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Products & Services
7.3.4.2.2. By Application
7.3.4.2.3. By End User
7.3.5. Spain Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Products & Services
7.3.5.2.2. By Application
7.3.5.2.3. By End User
8. Asia-Pacific Next Generation Sequencing (NGS) Informatics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Products & Services
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Products & Services
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. Japan Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Products & Services
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. India Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Products & Services
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. South Korea Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Products & Services
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Australia Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Products & Services
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. South America Next Generation Sequencing (NGS) Informatics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Products & Services
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Next Generation Sequencing (NGS) Informatics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Products & Services
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. Argentina Next Generation Sequencing (NGS) Informatics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Products & Services
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Colombia Next Generation Sequencing (NGS) Informatics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Products & Services
9.3.3.2.2. By Application
9.3.3.2.3. By End User
10. Middle East and Africa Next Generation Sequencing (NGS) Informatics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Products & Services
10.2.2. By Application
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. UAE Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Products & Services
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Products & Services
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. South Africa Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Products & Services
10.3.3.2.2. By Application
10.3.3.2.3. By End User
10.3.4. Turkey Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Products & Services
10.3.4.2.2. By Application
10.3.5. Egypt Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Products & Services
10.3.5.2.2. By Application
10.3.5.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.1.1. Rise in Prevalence of Chronic Diseases
11.1.2. Increase in clinical research for Next Generation Sequencing (NGS)
11.1.3. Substitution of DNA Microarray Technology
12. Challenges
12.1.1. Lack of trained clinical personnel for conducting Next Generation Sequencing (NGS) experiments
12.1.2. Poor reimbursement rates for Next Generation Sequencing (NGS) across the globe
13. Market Trends & Developments
14. Competitive Landscape
14.1. Business Overview
14.2. Product Offerings
14.3. Recent Developments
14.4. Financials (As Reported)
14.5. Key Personnel
14.5.1. Abbott Laboratories, Inc.
14.5.2. F. Hoffmann-La Roche Ltd.
14.5.3. PerkinElmer, Inc.
14.5.4. SOPHiA GENETICS SA
14.5.5. Precigen, Inc.
14.5.6. QIAGEN N.V.
14.5.7. Illumina, Inc.
14.5.8. Agilent Technologies, Inc.
14.5.9. Eagle Genomics Limited
14.5.10. BGI Genomics Co., Ltd.
15. Strategic Recommendations

 

ページTOPに戻る


 

Summary

Global Next Generation Sequencing (NGS) Informatics Market is anticipated to observe an impressive growth during the forecast period, 2024-2028 owing to growing prevalence of cancer and increase in clinical applications for Next Generation Sequencing (NGS). According to Global Cancer Observatory, in 2020, around 19,292,789 new cancer cases were reported worldwide. Breast Cancer, Lung Cancer, Colorectum Cancer, Prostate Cancer and Stomach Cancer were the most prevalent types of cancer cases reported in 2020. Additionally, increase in number of samples for DNA sequencing, reduced cost of DNA sequencing with the use of Next Generation Sequencing (NGS) informatics, various government initiatives, rising clinical applications, substitution of Microarray technology by Next Generation Sequencing (NGS) are other factors contributing to market growth.
The growing prevalence of new viral diseases has significantly increased the demand for Next Generation Sequencing (NGS) Informatics market. Additionally, growing research & development activities being initiated by various governments and pharmaceutical & biotechnology companies across the globe is further expected to create lucrative opportunities for the growth of Next Generation Sequencing (NGS) Informatics market in the coming years. In 2021, the research & development expenditure in the pharmaceutical industry across the globe was around USD238 billion.
Rise in Prevalence of Chronic Diseases
Globally, the cancer is the leading cause of death. According to World Health Organization, around 50,550,287 cases of cancer have been reported worldwide in the last five years. This is brought due to the presence of physical carcinogens like ultraviolet and ionising radiation, chemical carcinogens like asbestos, tobacco smoke, alcohol, aflatoxin (a food contaminant), and arsenic (a drinking water contaminant), and biological carcinogens like parasite infections and unhealthy lifestyle choices. A major issue in healthcare nowadays is cancer. The demand for novel cancer therapies is anticipated to fuel the expansion of the global Next Generation Sequencing (NGS) Informatics market.
. Similarly, the increasing prevalence of new viral diseases such as HIV, Human Papillomavirus and Tuberculosis which are deadly and require a potential treatment is further expected to drive the growth of global Next Generation Sequencing (NGS) Informatics Market. As of 2021, globally around 38.4 million people were living with HIV.

Increase in Clinical Research for Next Generation Sequencing (NGS)
Clinical research is medical research constituting two components: observational studies, clinical trials. The clinical research activities result in taking care of the human health by identifying the viral genome sequence through Next Generation Sequencing (NGS). The Next Generation Sequencing (NGS) technique plays a vital role in studying the mutations in the viral genome and their impact on human health as well. According to a research article published in Clinical OMICS, 2020, approximately 84,000 viral genomic sequences of the coronavirus have been uploaded to the Global Initiative to Share All Influenza Data (GISAID). Additionally, the application like whole genome and transcriptome sequencing, metagenomics, etc. is used for the characterization of different microbial samples which in turn is expected to fuel the growth of Global Next Generation Sequencing (NGS) Informatics Market.

Substitution of DNA Microarray Technology
With recent advancements and a radical decline in sequencing costs, the popularity of next generation sequencing (Next Generation Sequencing (NGS)) has skyrocketed. As costs become less prohibitive and methods become simpler and more widespread, researchers are choosing Next Generation Sequencing (NGS) over microarrays for more of their genomic applications. Additionally, Next Generation Sequencing (NGS) has the potential to offer even higher resolution and a more comprehensive view of the genome.
This clearly indicates that a lot of R&D is being done across the globe for utilizing Next Generation Sequencing (NGS) sequencing for the treatment of human health, thereby supporting the growth of global Next Generation Sequencing (NGS) Informatics Market.

Market Segmentation
Global Next Generation Sequencing (NGS) Informatics Market can be segmented based on products & services, application, end user, region and competitional landscape. Based on products & services, the market can be categorized into storage and computing tools, commercial data analysis, data interpretation, and reporting tools, Next Generation Sequencing (NGS), laboratory information management systems (LIMS). Based on application, the market can be fragmented into drug discovery, genetic screening, disease diagnosis, and others. Based on end user, the market can be divided into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, academic and research institutions.

Company Profiles
Abbott Laboratories, Inc., F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., SOPHiA GENETICS SA, Precigen, Inc., QIAGEN N.V., Illumina, Inc., Agilent Technologies, Inc., Eagle Genomics Limited, BGI Genomics Co., Ltd. are some of the key players operating in the Global Next Generation Sequencing (NGS) Informatics Market.

Report Scope:
In this report, Global Next Generation Sequencing (NGS) Informatics Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Next Generation Sequencing (NGS) Informatics Market, By Products & Services:
o Storage and Computing Tools
o Commercial Data Analysis
o Data Interpretation, and Reporting Tools
o Next Generation Sequencing (NGS)
o Laboratory Information Management Systems (LIMS)
• Next Generation Sequencing (NGS) Informatics Market, By Application:
o Drug Discovery
o Genetic Screening
o Disease Diagnosis
o Others
• Next Generation Sequencing (NGS) Informatics Market, By End User:
o Hospitals and Diagnostic Centers
o Pharmaceutical and Biotechnology Companies
o Academic and Research Institutions
• Next Generation Sequencing (NGS) Informatics Market, By Region:
o North America
 United States
 Canada
 Mexico
o Europe
 Germany
 France
 United Kingdom
 Italy
 Spain
o Asia-Pacific
 China
 Japan
 India
 South Korea
 Australia
o South America
 Brazil
 Argentina
 Colombia
o Middle East & Africa
 UAE
 Saudi Arabia
 South Africa
 Turkey
 Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Global Next Generation Sequencing (NGS) Informatics Market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).



ページTOPに戻る


Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Next Generation Sequencing (NGS) Informatics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Products & Services (Storage and Computing Tools, Commercial Data Analysis, Data Interpretation, and Reporting Tools, Next Generation Sequencing (NGS) Informatics Services, Laboratory Information Management Systems (LIMS))
5.2.2. By Application (Drug Discovery, Genetic Screening, Disease Diagnosis, and Others)
5.2.3. By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutions)
5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)
5.2.5. By Company (2022)
5.3. Market Map
5.3.1. By Products & Services
5.3.2. By Application
5.3.3. By End User
5.3.4. By Region
6. North America Next Generation Sequencing (NGS) Informatics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Products & Services
6.2.2. By Application
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Next Generation Sequencing (NGS) Informatics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Products & Services
6.3.1.2.2. By Application
6.3.1.2.3. By End User
6.3.2. Canada Next Generation Sequencing (NGS) Informatics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Products & Services
6.3.2.2.2. By Application
6.3.2.2.3. By End User
6.3.3. Mexico Next Generation Sequencing (NGS) Informatics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Products & Services
6.3.3.2.2. By Application
6.3.3.2.3. By End User
7. Europe Next Generation Sequencing (NGS) Informatics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Products & Services
7.2.2. By Application
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Products & Services
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.1.2.4. By Country
7.3.2. France Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Products & Services
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. United Kingdom Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Products & Services
7.3.3.2.2. By Application
7.3.3.2.3. By End User
7.3.4. Italy Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Products & Services
7.3.4.2.2. By Application
7.3.4.2.3. By End User
7.3.5. Spain Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Products & Services
7.3.5.2.2. By Application
7.3.5.2.3. By End User
8. Asia-Pacific Next Generation Sequencing (NGS) Informatics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Products & Services
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Products & Services
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. Japan Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Products & Services
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. India Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Products & Services
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. South Korea Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Products & Services
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Australia Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Products & Services
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. South America Next Generation Sequencing (NGS) Informatics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Products & Services
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Next Generation Sequencing (NGS) Informatics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Products & Services
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. Argentina Next Generation Sequencing (NGS) Informatics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Products & Services
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Colombia Next Generation Sequencing (NGS) Informatics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Products & Services
9.3.3.2.2. By Application
9.3.3.2.3. By End User
10. Middle East and Africa Next Generation Sequencing (NGS) Informatics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Products & Services
10.2.2. By Application
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. UAE Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Products & Services
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Products & Services
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. South Africa Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Products & Services
10.3.3.2.2. By Application
10.3.3.2.3. By End User
10.3.4. Turkey Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Products & Services
10.3.4.2.2. By Application
10.3.5. Egypt Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Products & Services
10.3.5.2.2. By Application
10.3.5.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.1.1. Rise in Prevalence of Chronic Diseases
11.1.2. Increase in clinical research for Next Generation Sequencing (NGS)
11.1.3. Substitution of DNA Microarray Technology
12. Challenges
12.1.1. Lack of trained clinical personnel for conducting Next Generation Sequencing (NGS) experiments
12.1.2. Poor reimbursement rates for Next Generation Sequencing (NGS) across the globe
13. Market Trends & Developments
14. Competitive Landscape
14.1. Business Overview
14.2. Product Offerings
14.3. Recent Developments
14.4. Financials (As Reported)
14.5. Key Personnel
14.5.1. Abbott Laboratories, Inc.
14.5.2. F. Hoffmann-La Roche Ltd.
14.5.3. PerkinElmer, Inc.
14.5.4. SOPHiA GENETICS SA
14.5.5. Precigen, Inc.
14.5.6. QIAGEN N.V.
14.5.7. Illumina, Inc.
14.5.8. Agilent Technologies, Inc.
14.5.9. Eagle Genomics Limited
14.5.10. BGI Genomics Co., Ltd.
15. Strategic Recommendations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(バイオ薬物)の最新刊レポート

TechSci Research 社の最新刊レポート

本レポートと同じKEY WORD(biotechnology)の最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/23 10:28

157.74 円

172.13 円

206.60 円

ページTOPに戻る